These findings are emphasized by the effect of three alternative CXCR7 inhibitors CCX771, CCX662 and X7Ab which led to tumor regression [55,84], blocked tumor recurrence [84] and increased survival [55] in several mouse models. The gene discussed is ACKR3; the disease is neoplasm.